You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

RCHOP

Showing 1 - 25 of 62
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Double Hit Lymphoma, Triple Hit Lymphoma Trial in Hangzhou (Selinexor+RCHOP)

Recruiting
  • Double Hit Lymphoma
  • Triple Hit Lymphoma
  • Hangzhou, Zhenjiang, China
    Zhejiang Cancer Hospital
Aug 2, 2023

Lymphoma, Large B-Cell, Diffuse Trial in Milan (NGR-hTNF, RITUXIMAB, Doxorubicin)

Completed
  • Lymphoma, Large B-Cell, Diffuse
  • Milan, Italy
    Ospedale San Raffaele
Aug 2, 2022

Diffuse Large B Cell Lymphoma Trial in Wuhan (Zanubrutinib plus RCHOP)

Recruiting
  • Diffuse Large B Cell Lymphoma
  • Zanubrutinib plus RCHOP
  • Wuhan, Hubei, China
    Union Hospital, Tongji Medical College, Huazhong University of S
Aug 16, 2023

Follicular Lymphoma Trial in Shanghai (BR for 6 cycles +R for 8 cycles, RCHOP for 6 cycles +R for 8 cycles, R2 for 6 cycles + R2

Recruiting
  • Follicular Lymphoma
  • BR for 6 cycles +R for 8 cycles
  • +2 more
  • Shanghai, China
    Ruijin Hospital
Apr 10, 2021

Diffuse Large B Cell Lymphoma Trial in Shanghai (zanubrutinib)

Recruiting
  • Diffuse Large B Cell Lymphoma
  • Shanghai, Shanghai, China
    Fudan University Shanghai Cancer Center
Mar 13, 2022

Diffuse Large B Cell Lymphoma Trial in Wenzhou (Zanubrutinib+Rituximab+Lenalidomide, RCHOP/RCDOP)

Recruiting
  • Diffuse Large B Cell Lymphoma
  • Wenzhou, Zhejiang, China
    First Affiliated Hospital of Wenzhou Medical University
Jun 20, 2022

Diffuse Large B Cell Lymphoma Trial in Hangzhou (Rituximab, Lenalidomide, Zanubrutinib and RCHOP)

Not yet recruiting
  • Diffuse Large B Cell Lymphoma
  • Rituximab, Lenalidomide, Zanubrutinib and RCHOP
  • Hangzhou, Zhejiang, China
    Zhejiang Cancer Hospital
Mar 21, 2022

Richter Syndrome Trial in France (RCHOP, Blinatumomab)

Active, not recruiting
  • Richter Syndrome
  • Amiens, France
  • +27 more
Jul 26, 2022

Diffuse B-Cell Lymphoma Trial in Worldwide (Avadomide (CC-122), Rituximab, Cyclophosphamide 750mg/m2 by IV infusion)

Completed
  • Diffuse B-Cell Lymphoma
  • Avadomide (CC-122)
  • +4 more
  • Washington, District of Columbia
  • +14 more
Apr 28, 2021

Mantle Cell Lymphoma, Untreated Trial in United States (Lenalidomide, R-CHOP, high-dose cytarabine (HIDAC))

Active, not recruiting
  • Mantle Cell Lymphoma
  • Untreated
  • Basking Ridge, New Jersey
  • +6 more
Feb 17, 2022

Lymphoma, Large B-Cell, Diffuse, Lymphoma, Follicular Trial in United States (Oral Azacitidine, Rituximab, cyclophosphamide)

Completed
  • Lymphoma, Large B-Cell, Diffuse
  • Lymphoma, Follicular
  • Oral Azacitidine
  • +4 more
  • Tampa, Florida
  • +6 more
Aug 26, 2020

Lymphomas Non-Hodgkin's B-Cell Trial in Ballarat, Box Hill, Heidelberg (Avelumab)

Active, not recruiting
  • Lymphomas Non-Hodgkin's B-Cell
  • Ballarat, Victoria, Australia
  • +2 more
Jan 30, 2023

Mantle Cell Lymphoma Trial in Busan (Ixazomib)

Recruiting
  • Mantle Cell Lymphoma
  • Busan, Western, Korea, Republic of
    Kosin University Gospel Hospital
Mar 31, 2022

B-Cell Non-Hodgkin Lymphoma Trial in China (Epcoritamab, Cyclophosphamide, Rituximab)

Recruiting
  • B-Cell Non-Hodgkin Lymphoma
  • Beijing, Beijing, China
  • +20 more
May 31, 2022

Diffuse Large B-cell Lymphoma(DLBCL) Trial in Shanghai (Zanubrutinib + R-CHOP)

Recruiting
  • Diffuse Large B-cell Lymphoma(DLBCL)
  • Zanubrutinib + R-CHOP
  • Shanghai, China
    Fudan University Shanghai Cancer Center
Feb 10, 2022

Diffuse Large B Cell Lymphoma Trial in France (ONCOLAXY Follow-up)

Not yet recruiting
  • Diffuse Large B Cell Lymphoma
  • ONCOLAXY Follow-up
  • Bordeaux, France
  • +4 more
Mar 25, 2022

Relapsed Follicular Lymphoma, Refractory Follicular Lymphoma Trial in United Kingdom (Epcoritamab, Lenalidomide, Rituximab)

Not yet recruiting
  • Relapsed Follicular Lymphoma
  • Refractory Follicular Lymphoma
  • Aberdeen, United Kingdom
  • +24 more
Apr 28, 2023

Diffuse Large B Cell Lymphoma, CNS Lymphoma Trial in Beijing (Methotrexate)

Recruiting
  • Diffuse Large B Cell Lymphoma
  • Central Nervous System Lymphoma
  • Beijing, Beijing, China
    Peking union medical college hospital
Sep 21, 2021

Diffuse Large B Cell Lymphoma Trial in Saint Louis (18F-FluorApoTrace)

Recruiting
  • Diffuse Large B Cell Lymphoma
  • Saint Louis, Missouri
    Washington University School of Medicine
Dec 7, 2021

Lymphoma, DLBCL, Follicular Lymphoma Trial in Belgium, France (Tazemetostat, Rituximab, Cyclophosphamide)

Recruiting
  • Lymphoma
  • +2 more
  • Bruxelles, Belgium
  • +30 more
Jul 23, 2021

Composite Lymphoma, Grade 3b Follicular Lymphoma, Stage I DLBCL Trial in Seattle (drug, other, biological)

Completed
Has Results
  • Composite Lymphoma
  • +9 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Sep 22, 2020

Diffuse Large B-cell Lymphoma Trial in Switzerland (Acalabrutinib)

Recruiting
  • Diffuse Large B-cell Lymphoma
  • Bergamo, Italy
  • +16 more
Jan 17, 2023

Diffuse, Large B-Cell, Lymphoma, Follicular Lymphoma, Grade 3b, Transformed Lymphoma / DLBCL Trial in Puerto Rico, United States

Terminated
Has Results
  • Diffuse, Large B-Cell, Lymphoma
  • +2 more
  • denintuzumab mafodotin
  • +5 more
  • Birmingham, Alabama
  • +34 more
Feb 11, 2019

Lymphoma Trial in Spain (RCOMP, RCHOP)

Unknown status
  • Lymphoma
  • Vitoria, Alava, Spain
  • +13 more
Jan 8, 2020

Diffuse Large B Cell Lymphoma Trial in Shanghai (Cyclophosphamide, Rituximab, Doxorubicin)

Recruiting
  • Diffuse Large B Cell Lymphoma
  • Shanghai, Shanghai, China
    Ruijin hospital
Nov 17, 2020